Physician profile
Paul E Fenn
NPI 1720006687
$3,713.02
in general payments reported to CMS, 2019-2025
15 companies · $669 in 2025
The $669 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,234 · 2020: $369 · 2021: $193 · 2022: $1,200 · 2023: $47.41 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $439 · Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $438.61 |
| Food and Beverage | $278.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,216.18 | 2019-2020 | |
| Alon Medical Technology | $1,200.00 | 2022 | |
| Arthrex, INC. | $438.61 | 2025 | |
| Next Science LLC | $143.91 | 2020-2025 | Blastx, Xperience |
| Musculoskeletal Transplant Foundation INC. | $107.15 | 2020 | |
| Terumo Bct, INC. | $106.56 | 2020 | |
| In2bones USA, LLC | $105.50 | 2021 | |
| Zimmer Biomet Holdings, INC. | $71.00 | 2019 | |
| Stryker Corporation | $69.03 | 2025 | Easyfuse |
| Pacira Therapeutics, INC. | $52.50 | 2019-2021 | |
| Dynasplint Systems INC. | $49.83 | 2021 | |
| Carbofix Orthopedics INC | $47.41 | 2023 | |
| Biom'Up France Sas | $43.56 | 2020 | |
| Philips North America LLC | $39.47 | 2019 | |
| Spinal Simplicity, LLC | $22.31 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Fenn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.